Agilis Pharmaceuticals LLP

Agilis Pharmaceuticals LLP - paper in Mumbai, Maharashtra, India. Directors, charges & compliance details.
LLPIN ABB-8641 Incorporated 25 July 2022 ROC Mumbai HQ Mumbai, Maharashtra, India
Pending Strike Off Limited Liability Partnership paper
Contribution obligation
₹1 Lakh
As per LLP agreement
LLP age
4 yrs
Est. 2022
Designated partners
2
As per MCA filings
LLP status
Under Process of Striking Off
MCA master data
Registrar
Mumbai
ROC office
Incorporated
25 Jul 2022
Date of incorporation
Entity type
LLP
As registered with MCA

About Agilis Pharmaceuticals LLP

Data last updated:

Agilis Pharmaceuticals LLP is a limited liability partnership (LLP) based in Mumbai, Maharashtra, India. The LLP is currently under process of striking off by the Registrar of Companies. The removal process has been initiated but is not yet final, and the LLP may be struck off soon. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 25 July 2022.

The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN ABB-8641.

The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Mitesh Jayantilal Doshi and Ruchi Nimish Siria.

The registered office is at Sector 3, Mumbai, Maharashtra.

Company details

LLPIN ABB-8641
Incorporation Date 25 July 2022
Total Obligation of Contribution ₹1 Lakh
ROC Mumbai
Company Status Under Process of Striking Off

Contact details

Agilis Pharmaceuticals LLP's registered office is in Mumbai, Maharashtra.

  • Registered Address
    Off – 136 Kesar Residency Chs Ltd, Sector 3 Near Charkop Market, Mumbai, Maharashtra, India – 400067
  • Industry
    Paper, Paper & Paper Products, Manufacturing
Comprehensive company report
Agilis Pharmaceuticals LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Agilis Pharmaceuticals LLP

Year-wise financial statements and ratios of Agilis Pharmaceuticals LLP are in the company report Buy the company report.

Designated partners of Agilis Pharmaceuticals LLP

Agilis Pharmaceuticals has 2 designated partners on record. No former designated partners are listed.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Mitesh Jayantilal DoshiDesignated Partner25 Jul 20224 Years 3 MonthsCurrent
Ruchi Nimish SiriaDesignated Partner25 Jul 20224 Years 3 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Agilis Pharmaceuticals LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Agilis Pharmaceuticals LLP; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Agilis Pharmaceuticals LLP has 2 designated partner changes on record since 2022: 2 appointments. The latest: Mitesh Jayantilal Doshi was appointed as Designated Partner on 25 Jul 2022.

AGM
Agilis Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2023 as per latest MCA records.
Appointed
Mitesh Jayantilal Doshi was appointed as Designated Partner.
Appointed
Ruchi Nimish Siria was appointed as Designated Partner.
Incorporation
25 Jul 2022
Agilis Pharmaceuticals Llp was registered on 25 Jul 2022 with Roc Mumbai & aged 4 years 3 months as per MCA records.

Frequently asked questions

Agilis Pharmaceuticals is currently "Under Process of Striking Off" as per MCA records. The Registrar of Companies has initiated the process to remove the LLP from the register, typically due to non-filing of statutory returns. This process is not yet final, but the LLP may be struck off soon. Caution is advised before entering into any agreements with this entity.

Agilis Pharmaceuticals is a company pending strike off, currently registered as a limited liability partnership based in Mumbai, Maharashtra, India. The LLP works in paper and paper products, within the paper industry. It was incorporated on 25 July 2022 and is registered under LLPIN ABB-8641. The LLP may be struck off soon - caution is advised.

Agilis Pharmaceuticals has 2 current designated partners:

The LLPIN (Limited Liability Partnership Identification Number) of Agilis Pharmaceuticals is ABB-8641. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Agilis Pharmaceuticals was incorporated on 25 July 2022. It is registered with the Registrar of Companies, Mumbai.

The registered office of Agilis Pharmaceuticals is at Off – 136 Kesar Residency Chs Ltd, Sector 3 Near Charkop Market, Mumbai, Maharashtra, India – 400067.

Agilis Pharmaceuticals operates in the paper industry, in the paper and paper products segment.

Mitesh Jayantilal Doshi was appointed as Designated Partner on 25 Jul 2022. Ruchi Nimish Siria was appointed as Designated Partner on 25 Jul 2022.

Agilis Pharmaceuticals can be reached at its registered office: Off – 136 Kesar Residency Chs Ltd, Sector 3 Near Charkop Market, Mumbai, Maharashtra, India – 400067.

Agilis Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.